Sana Biotechnology, Inc.
NASDAQSANA enters its May 14 earnings report carrying one of the most crowded short books in its sector — and the bears have not blinked. Short interest runs at 14.5% of the free float, a level that places the stock in the 2nd percentile of short-score rankings across the universe. The ORTEX short score has held above 82 for the past two weeks without a meaningful pullback, signalling…
Snapshot as of 25 Jun 2026
SANA enters its May 14 earnings report carrying one of the most crowded short books in its sector — and the bears have not blinked. Short interest runs at 14.5% of the free float, a level that places the stock in the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SANA — free to start on ORTEX.
Sign up for free →Open SANA on ORTEX